Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic agents and substantial mortality. It is critical to find new treatments.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): JAMA

Title: JAMA

Publisher: American Medical Association (AMA)

ISSN (Electronic): 1538-3598

ISSN (Print): 0098-7484

Publication date (Electronic): April 28 2020

Volume: 323

Issue: 16

Affiliations

[1 ] Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.

[2 ] Laboratory of Protein Engineering and Vaccines, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences (CAS), Tianjin, China.

Article

Publisher Item ID: 2763983

DOI: 10.1001/jama.2020.4783

PMC ID: 7101507

PubMed ID: 32219428

SO-VID: ce37bb96-051f-4a1c-8c65-941794833dc9

History

Data availability:

Comments

Comment on this article

scite_

Cited by 1,096

See all cited by